definiens: means any and all information provided by [COMPANY] related to M ASP-2 Historical Information or Proposals or relati ng to the following technology that was licensed, acqu ired, developed or are owned and/or held by [COMPANY] : methods, antibodies and other agents and compositio ns for the inhibition of the complement immune syst em, including without limitation information developed by [COMPANY] and/or obtained from the University of Leicester, the UK Medical Research Council and/or F ukushima Medical University regarding MASP-2 or MAp19 as well as methods for inhibiting the same ; a nd includes, without limitation, research and development information, know - how, legal analysis, inventions, trade secrets, technical data, knock - ou t and knock - in mouse strains, gene expression profiles, b ehavioral and physiological assays, phenotypes, cel l lines, cellular, biochemical and chemical assays, c hemical structures, formulae, treatment methods, cl inical trial design criteria, protocols, case report forms ( blank or including patient data ), investigators ’ brochures, drawings, designs, models, samples, processes, chem istry, manufacturing and controls information, regulatory information, and any type of product dev elopment, business or marketing plans or strategies or financial information